Skip to main content
OpenTrials
Completed

NCT Number: NCT03972839

Comparison of Two D-Dimers Dosing Techniques

Study of the possibility of substitution of the automated STAGO D-Dimers method with the semi-automated VIDAS method, which is more expensive, longer to implement and requires the use of a dedicated automaton.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Blood Coagulation Disorder Blood Coagulation Disorders Cardiovascular Diseases Embolism and Thrombosis Hematologic Diseases Hemic and Lymphatic Diseases Thrombosis Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHRU de Brest

Brest, 29609, France

About this study

To compare D-Dimer assay techniques in the exclusion of VTE (Thromboembolic Venous Disease):• BIOMERIEUX: D-Dimers VIDAS (considered as reference technique)• STAGO: D-Di PlusOn a population of patients recruited in Brest for a period of 1 year: patients for whom a dosage of VIDAS D-dimers is prescribed (approximately 3700 patients)

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients for whom a dosage of D-Dimers VIDAS is prescribed in the context of a suspicion of VTE at Brest CHRU.
  • No opposition formulated.

Exclusion criteria

  • Curative dose anticoagulant treatment whatever the indication,
  • Pregnancy in progress,
  • Follow-up at 3 months not possible,
  • Patient refusing to participate

Treatment and study plan

Primary outcomes

  1. Biomerieux D-Dimer level

    Time frame: at the inclusion

    quantification of Biomerieux D-Dimer level (VIDAS)

  2. Stago D-Dimer level

    Time frame: at the inclusion

    quantification of Biomerieux D-Dimer level (STAGO)

Sponsors and collaborators

Lead sponsor

University Hospital, Brest

Other

Registry information

Official study title

Comparison of Two D-Dimers Dosing Techniques : LIATEST DDI PLUS (STAGO) Versus VIDAS D-DIMERS (BIOMERIEUX)

Acronym: COMPADDI

Important dates

Study start
2019
Primary completion
2020
Study completion
2021
First posted
Jun 4, 2019
Registry last updated
Jun 7, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.